KNSA · Kiniksa Pharmaceuticals International, plc · Metrics
$93.90
+0.36 (+0.38%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.38B
Shares
78.57M
Volume · Nov 20
545.23K
Avg daily vol (3M)
658.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
KNSA metrics
95 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$93.90
Market cap
$7.38B
Price action
23 metricsPrice change (1W)
-2.5%
Price change (30D)
+16.2%
Price change (3M)
+18.8%
Price change (6M)
+76.4%
Price change (YTD)
+127.6%
Price change (1Y)
+126.3%
Trailing year
Price change (5Y)
+669.6%
52-week high
$98.76
52-week low
$37.92
Change from 52-week high
-4.9%
Change from 52-week low
+147.6%
Annualized volatility
56.3%
Annualized volatility (3M)
60.2%
Implied volatility (30D)
50.7%
IV rank (1Y)
19.2
IV percentile (1Y)
43.5
Beta
0.7
RSI (14D)
55.8
Price vs SMA 50
+11.9%
Price vs SMA 200
+46.5%
Avg volume (3M)
658,718
Relative volume
0.8
Average dollar volume
$55.22M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
78.57M
Valuation
12 metricsP / E (TTM)
71.7
Trailing earnings · reciprocal yield 1.4%
PEG ratio
0.5
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.8×
reciprocal yield 12.8%
P / book
10.4
reciprocal yield 9.6%
FCF yield
2.7%
TTM · current market cap
Buyback yield
—
P / FCF
37.4
reciprocal yield 2.7%
P / operating cash flow
37.1
reciprocal yield 2.7%
Earnings yield
1.5%
Historical valuation
8 metricsP / E historical average (3Y)
176.3×
reciprocal yield 0.6%
P / E historical average (5Y)
119.4×
reciprocal yield 0.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-27
Profitability
9 metricsGross margin
90.2%
Operating margin
13.8%
Trailing 12 months
Net margin
11.6%
Gross profit (TTM)
$852.89M
Operating profit (TTM)
$130.47M
Net income (TTM)
$109.57M
Trailing 12 months
Diluted EPS (TTM)
$1.31
FCF margin
20.8%
Effective tax rate
25.0%
Growth
11 metricsRevenue growth YoY
+58.1%
Year over year
Net income growth YoY
+156.8%
Revenue (TTM)
$945.96M
Trailing 12 months
EPS growth YoY
+143.5%
Shares change YoY
+6.1%
Year over year · more shares
Revenue CAGR (3Y)
+45.5%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
-33.9%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+188.1%
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
15.4%
Return on assets
11.1%
Debt / equity
—
Current ratio
3.9
EBITDA (TTM)
$132.36M
Free cash flow (TTM)
$197.20M
Quick ratio
3.3
Interest coverage
—
Net debt / EBITDA
-4.3
Return on invested capital
—
Trailing 12 months
Net cash
$568.76M
Latest balance sheet
Cash & equivalents
$81.66M
Total assets
$983.24M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$198.84M
Capital expenditures (TTM)
$1.64M
R&D (TTM)
$135.77M
SG&A (TTM)
$247.15M
Stock compensation (TTM)
$44.99M
R&D / revenue
14.4%
Stock compensation / revenue
4.8%
Ownership (13F)
9 metrics13F filers
304
13F filer change QoQ
+39
Institutional ownership
60.3%
Conviction holders (share of 13F filers)
2.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.8%
Holder tenure
8.0
Price vs estimated holder cost
+89.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
3.9%
Short interest
3 metricsShort interest
5.5%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
66 / 100
Insider activity
2 metricsNet insider buying (90D)
−$78.59M
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1730430
CUSIP
G52694109
13F (30d)
280 filings
272 filers
Visit website
Investor relations